Hypoxia Exacerbates Periapical Periodontitis-Associated Pathological Bone Loss via the Hypoxia-Inducible Factor-2α-Calmodulin-Dependent Protein Kinase IV Axis

Kang Gao; Yifan Xu; Haoran Du; Zixiao Li; Xiaochen Fang; Minghui Wang; Jia Liu; Xu Zha; Xianglong Han; Weihua Guo; Xicheng Liu; Jian Zhou

doi:10.1111/cpr.70160

Cell Proliferation ›› 2026, Vol. 59 ›› Issue (7) :e70160 DOI: 10.1111/cpr.70160

ORIGINAL ARTICLE

Hypoxia Exacerbates Periapical Periodontitis-Associated Pathological Bone Loss via the Hypoxia-Inducible Factor-2α-Calmodulin-Dependent Protein Kinase IV Axis

Kang Gao ¹^,²^,³
, Yifan Xu ²^,³^,⁴^,⁵
, Haoran Du ¹^,²^,³
, Zixiao Li ¹^,²^,³
, Xiaochen Fang ¹^,²^,³
, Minghui Wang ¹^,²^,³
, Jia Liu ⁶
, Xu Zha ⁵^,⁷
, Xianglong Han ⁸^,⁹
, Weihua Guo ¹⁰
, Xicheng Liu ⁵^,⁷
, Jian Zhou ¹^,²^,³^,⁵^,¹¹

Author information +

¹. Department of International Medical Center, Beijing Stomatological Hospital, Capital Medical University, Beijing, China

². Salivary Gland Disease Center and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China

³. Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China

⁴. Department of Dental Implant Center, Beijing Stomatological Hospital, Capital Medical University, Beijing, China

⁵. Laboratory for Clinical Medicine, Capital Medical University, Beijing, China

⁶. Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Capital Medical University, Beijing, China

⁷. Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China

⁸. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China

⁹. Department of Orthodontics and Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China

¹⁰. Yunnan Key Laboratory of Stomatology & Department of Pediatric Dentistry, The Affiliated Stomatology Hospital, Kunming Medical University, Kunming, China

¹¹. Laboratory for Oral and General Health Integration and Translation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

zhoujian@ccmu.edu.cn

Show less

History +

PDF (21252KB)

Abstract

Periapical periodontitis is one of the most common inflammatory bone destructive diseases. Epidemiological evidence suggests that hypoxia exposure, such as that resulting from high-altitude exposure or sleep apnea syndrome, may be a significant risk factor that exacerbates the disease process. However, its specific role and the underlying molecular mechanisms remain unclear. In this study, we established a mouse model of periapical periodontitis under conditions of chronic hypoxia to evaluate its impact on pathological bone loss using micro-computed tomography, histological staining, and serum cytokine analysis. Furthermore, we explored the potential molecular regulatory mechanisms using in vitro osteoclast differentiation models, adeno-associated virus-mediated in vivo gene knockdown, and cleavage under targets and tagmentation (CUT&Tag) sequencing. Our study revealed that hypoxia exposure significantly aggravated alveolar bone resorption, osteoclast activation, and systemic inflammation in the mouse model of periapical periodontitis compared to normoxia. At the molecular level, hypoxia-inducible factor-1α (HIF-1α) showed a rapid but transient increase under hypoxia, whereas HIF-2α displayed a progressive and sustained elevation throughout osteoclast differentiation. These dynamics indicate that HIF-2α plays a more prominent role than HIF-1α in mediating the hypoxia-accelerated osteoclastogenic response. In vivo, local knockdown of HIF-2α in the periapical region markedly attenuated bone destruction exacerbated by hypoxia exposure. Further mechanistic investigation, combining CUT&Tag sequencing and functional validation experiments, revealed that HIF-2α mediates its pro-osteoclastogenic function by directly binding to the promoter region of the calmodulin-dependent protein kinase IV (Camk4) gene and activating its transcription. This study unveils that hypoxia exposure, acting as a critical environmental risk factor, functions as a ‘synergistic amplifier’ to enhance pathological osteoclastic responses in periapical periodontitis through the HIF-2α–CAMK4 regulatory axis. The findings deepen our understanding of periapical periodontitis and suggest that targeting HIF-2α or downstream pathways may be an adjunctive therapeutic strategy for hypoxia-associated inflammatory bone loss.

Keywords

bone resorption / CAMK4 / hypoxia / hypoxia-inducible factor-2α / periapical periodontitis

Cite this article

Download citation ▾

Kang Gao, Yifan Xu, Haoran Du, Zixiao Li, Xiaochen Fang, Minghui Wang, Jia Liu, Xu Zha, Xianglong Han, Weihua Guo, Xicheng Liu, Jian Zhou. Hypoxia Exacerbates Periapical Periodontitis-Associated Pathological Bone Loss via the Hypoxia-Inducible Factor-2α-Calmodulin-Dependent Protein Kinase IV Axis. Cell Proliferation, 2026, 59 (7) : e70160 DOI:10.1111/cpr.70160

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	X. Luo, Q. Wan, L. Cheng, and R. Xu, “Mechanisms of Bone Remodeling and Therapeutic Strategies in Chronic Apical Periodontitis,” Frontiers in Cellular and Infection Microbiology 12 (2022): 908859, https://doi.org/10.3389/fcimb.2022.908859.

[2]	J. She, F. Feng, X. Zhou, Y. He, C. Chen, and W. Zhang, “Oral Health Status of Air Force Personnel on Plateau and on Plain,” Journal of Military Surgery of Southwest China 18, no. 2 (2016): 101–103.

[3]	H. Choudhry and A. L. Harris, “Advances in Hypoxia-Inducible Factor Biology,” Cell Metabolism 27, no. 2 (2018): 281–298, https://doi.org/10.1016/j.cmet.2017.10.005.

[4]	A. Loboda, A. Jozkowicz, and J. Dulak, “HIF-1 Versus HIF-2—Is One More Important Than the Other?,” Vascular Pharmacology 56, no. 5–6 (2012): 245–251, https://doi.org/10.1016/j.vph.2012.02.006.

[5]	H. J. Knowles, “Distinct Roles for the Hypoxia-Inducible Transcription Factors HIF-1α and HIF-2α in Human Osteoclast Formation and Function,” Scientific Reports 10, no. 1 (2020): 21072, https://doi.org/10.1038/s41598-020-78003-z.

[6]	X. Meng, B. Wielockx, M. Rauner, and A. Bozec, “Hypoxia-Inducible Factors Regulate Osteoclasts in Health and Disease,” Frontiers in Cell and Development Biology 9 (2021): 658893, https://doi.org/10.3389/fcell.2021.658893.

[7]	S. Y. Lee, K. H. Park, G. Lee, et al., “Hypoxia-Inducible Factor-2α Mediates Senescence-Associated Intrinsic Mechanisms of Age-Related Bone Loss,” Experimental & Molecular Medicine 53, no. 4 (2021): 591–604, https://doi.org/10.1038/s12276-021-00594-y.

[8]	I. B. F. Petean, A. C. Silva-Sousa, R. A. B. da Silva, et al., “Systemic Inhibition of 5-Lipoxygenase by MK-886 Exacerbates Apical Periodontitis Bone Loss in a Mouse Model,” BMC Oral Health 23, no. 1 (2023): 11, https://doi.org/10.1186/s12903-023-02712-w.

[9]	Y. Xu, Y. Sa, C. Zhang, et al., “A Preventative Role of Nitrate for Hypoxia-Induced Intestinal Injury,” Free Radical Biology & Medicine 213 (2024): 457–469, https://doi.org/10.1016/j.freeradbiomed.2024.01.030.

[10]	X. Yun, S. Niedermeyer, M. R. Andrade, et al., “Aquaporin 1 Confers Apoptosis Resistance in Pulmonary Arterial Smooth Muscle Cells From the SU5416 Hypoxia Rat Model,” Physiological Reports 12, no. 16 (2024): e16156, https://doi.org/10.14814/phy2.16156.

[11]

X. He, Z. Wu, J. Jiang, et al., “Urolithin A Protects Against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling,” International Journal of Molecular Sciences 25, no. 15 (2024): 8246, https://doi.org/10.3390/ijms25158246.

[12]	X. Xie, W. Chen, M. Xu, et al., “IKK/NF-κB and ROS Signal Axes Are Involved in Tenacissoside H Mediated Inhibitory Effects on LPS-Induced Inflammatory Osteolysis,” Cell Proliferation 57, no. 1 (2024): e13535, https://doi.org/10.1111/cpr.13535.

[13]	Y. Xu, C. Zhou, X. Liu, W. Guo, and J. Zhou, “Application of Animal Models in Research on Hypoxia-Related Diseases,” Sichuan Da Xue Xue Bao. Yi Xue Ban 56, no. 2 (2025): 331–338, https://doi.org/10.12182/20250360101.

[14]	L. Han, T. Huang, Z. Zhao, and Z. Dang, “Cardiopulmonary Injury in Hypoxia and Selenium: A Review,” Journal of Trace Elements in Medicine and Biology 92 (2025): 127767, https://doi.org/10.1016/j.jtemb.2025.127767.

[15]	W. Łagowski, O. Grodzka, and I. Domitrz, “Atypical Neurological Symptoms at High Altitude: A Systematic Literature Review,” Travel Medicine and Infectious Disease 66 (2025): 102867, https://doi.org/10.1016/j.tmaid.2025.102867.

[16]	X. Wang, Z. Wu, Y. Zhang, B. Lian, L. Ma, and J. Zhao, “Autophagy Induced by Hypoxia in Pulpitis Is Mediated by HIF-1α/BNIP3,” Archives of Oral Biology 159 (2024): 105881, https://doi.org/10.1016/j.archoralbio.2024.105881.

[17]	J. K. Tan, N. S. Mohamad Hazir, and E. Alias, “Impacts of Hypoxia on Osteoclast Formation and Activity: Systematic Review,” International Journal of Molecular Sciences 22, no. 18 (2021): 10146, https://doi.org/10.3390/ijms221810146.

[18]	K. Yan, C. Wu, Y. Ye, et al., “A20 Inhibits Osteoclastogenesis via TRAF6-Dependent Autophagy in Human Periodontal Ligament Cells Under Hypoxia,” Cell Proliferation 53, no. 3 (2020): e12778, https://doi.org/10.1111/cpr.12778.

[19]	Y. H. Wen, Y. X. Lin, L. Zhou, C. Lin, and L. Zhang, “The Immune Landscape in Apical Periodontitis: From Mechanism to Therapy,” International Endodontic Journal 57, no. 11 (2024): 1526–1545, https://doi.org/10.1111/iej.14125.

[20]	P. Natarajan, S. Madanian, and S. Marshall, “Investigating the Link Between Oral Health Conditions and Systemic Diseases: A Cross-Sectional Analysis,” Scientific Reports 15, no. 1 (2025): 10476, https://doi.org/10.1038/s41598-025-92523-6.

[21]	S. Y. Lee, S. J. Kim, K. H. Park, et al., “Differential but Complementary Roles of HIF-1α and HIF-2α in the Regulation of Bone Homeostasis,” Communications Biology 7, no. 1 (2024): 892, https://doi.org/10.1038/s42003-024-06581-z.

[22]	M. Z. Bakleh and A. Al Haj Zen, “The Distinct Role of HIF-1α and HIF-2α in Hypoxia and Angiogenesis,” Cells 14, no. 9 (2025): 673, https://doi.org/10.3390/cells14090673.

[23]	S. Y. Lee, K. H. Park, H. G. Yu, et al., “Controlling Hypoxia-Inducible Factor-2α Is Critical for Maintaining Bone Homeostasis in Mice,” Bone Research 7 (2019): 14.

[24]	K. Sato, A. Suematsu, T. Nakashima, et al., “Regulation of Osteoclast Differentiation and Function by the CaMK-CREB Pathway,” Nature Medicine 12, no. 12 (2006): 1410–1416, https://doi.org/10.1038/nm1515.

[25]	T. Koga, M. Umeda, N. Yoshida, et al., “Inhibition of Calcium/Calmodulin-Dependent Protein Kinase IV in Arthritis: Dual Effect on Th17 Cell Activation and Osteoclastogenesis,” Rheumatology 62, no. 2 (2023): 861–871, https://doi.org/10.1093/rheumatology/keac381.

[26]	W. J. Boyle, W. S. Simonet, and D. L. Lacey, “Osteoclast Differentiation and Activation,” Nature 423, no. 6937 (2003): 337–342, https://doi.org/10.1038/nature01658.

[27]	N. Takegahara, H. Kim, and Y. Choi, “Unraveling the Intricacies of Osteoclast Differentiation and Maturation: Insight Into Novel Therapeutic Strategies for Bone-Destructive Diseases,” Experimental & Molecular Medicine 56, no. 2 (2024): 264–272, https://doi.org/10.1038/s12276-024-01157-7.

[28]	J. C. Dong, Y. Liao, W. Zhou, et al., “Porphyromonas gingivalis LPS-Stimulated BMSC-Derived Exosome Promotes Osteoclastogenesis via miR-151-3p/PAFAH1B1,” Oral Diseases 31, no. 1 (2025): 206–216, https://doi.org/10.1111/odi.15031.

[29]	B. C. Jeong, T. S. Kim, H. S. Kim, S. H. Lee, and Y. Choi, “Transmembrane Protein 64 Reciprocally Regulates Osteoblast and Adipocyte Differentiation by Modulating Wnt/β-Catenin Signaling,” Bone 78 (2015): 165–173, https://doi.org/10.1016/j.bone.2015.05.009.

[30]	H. Kim, T. Kim, B. C. Jeong, et al., “Tmem64 Modulates Calcium Signaling During RANKL-Mediated Osteoclast Differentiation,” Cell Metabolism 17, no. 2 (2013): 249–260, https://doi.org/10.1016/j.cmet.2013.01.002.

[31]	P. N. Nair, “On the Causes of Persistent Apical Periodontitis: A Review,” International Endodontic Journal 39, no. 4 (2006): 249–281, https://doi.org/10.1111/j.1365-2591.2006.01099.x.

[32]	K. Karamifar, A. Tondari, and M. A. Saghiri, “Endodontic Periapical Lesion: An Overview on the Etiology, Diagnosis and Current Treatment Modalities,” European Endodontic Journal 5, no. 2 (2020): 54–67, https://doi.org/10.14744/eej.2020.42714.

[33]	A. Aminoshariae, J. Kulild, and J. Gutmann, “The Association Between Smoking and Periapical Periodontitis: A Systematic Review,” Clinical Oral Investigations 24, no. 2 (2020): 533–545, https://doi.org/10.1007/s00784-019-03094-6.

[34]

K. P. Pinto, C. M. Ferreira, L. C. Maia, L. M. Sassone, T. K. S. Fidalgo, and E. Silva, “Does Tobacco Smoking Predispose to Apical Periodontitis and Endodontic Treatment Need? A Systematic Review and Meta-Analysis,” International Endodontic Journal 53, no. 8 (2020): 1068–1083, https://doi.org/10.1111/iej.13316.

[35]	C. Y. Hong, S. K. Lin, H. W. Wang, et al., “Metformin Reduces Bone Resorption in Apical Periodontitis Through Regulation of Osteoblast and Osteoclast Differentiation,” Journal of Endodontics 49, no. 9 (2023): 1129–1137, https://doi.org/10.1016/j.joen.2023.07.005.

[36]	Y. Song, S. Park, H. Jin, B. Hyun, and K. Y. Oh, “Involvement of the Programmed Death 1/Programmed Death Ligand 1 Pathway in the Immune Microenvironment of Chronic Periapical Lesions,” International Dental Journal 75, no. 4 (2025): 100874, https://doi.org/10.1016/j.identj.2025.100874.

[37]	C. T. Taylor and S. P. Colgan, “Regulation of Immunity and Inflammation by Hypoxia in Immunological Niches,” Nature Reviews Immunology 17, no. 12 (2017): 774–785, https://doi.org/10.1038/nri.2017.103.